Siga, ViroPharma, National Institutes of Health deal

SIGA completed its purchase of antiviral programs from VPHM targeting potential biological warfare agents for $1 million in cash and 1 million SIGA shares, worth about $1.5 million based on SIGA's Aug. 24 closing price of $1.48 (see BioCentury, June 14). ...